FIELD: medicine.
SUBSTANCE: perform assay by ordering or hypouricemic preparation in the higher therapeutic dose for 3-4 days with the subsequent reduction of a dose to average therapeutic or use various combinations of the hypouricemic preparation in average therapeutic doses. At occurrence within 12 days of carrying out of assay of acute arthritis diagnose gout.
EFFECT: increase of accuracy of gout diagnostics.
5 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CHOOSING TACTICS FOR TREATING PATIENTS WITH PURINE EXCHANGE DISORDERS | 2003 |
|
RU2273032C2 |
| METHOD OF PREDICTING EXACERBATION OF GOUTY ARTHRITIS | 0 |
|
SU1545159A1 |
| METHODS AND COMPOSITIONS FOR TREATING HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA | 2012 |
|
RU2603050C2 |
| COMBINED USE OF COMPOUND A AND COMPOUND B FOR PRODUCTION OF DRUGS FOR TREATMENT OF GOUT OR HYPERURICEMIA | 2019 |
|
RU2783862C1 |
| USING IL-1 ANTAGONISTS FOR TREATING GOUT | 2007 |
|
RU2450824C2 |
| METHOD FOR TREATING THE CASES OF GOUT BY ADMINISTERING PLASMOSORPTION | 2001 |
|
RU2219957C2 |
| METHODS AND SETS FOR PREDICTING RISK OF INFUSION RESPONSES AND ANTIBODY-MEDIATED LOSS OF RESPONSE IN THERAPY WITH PEGYLATED URICASE BY MONITORING URIC ACID CONTENT IN BLOOD SERUM | 2010 |
|
RU2535038C2 |
| METHOD OF ASSAY OF OPTIMAL INCUBATION TIME OF BLOOD PLASMA WITH SORBENT | 2001 |
|
RU2200027C1 |
| METHODS FOR PRESERVING RENAL FUNCTION WITH USING XANTHINE OXIDOREDUCTASE | 2007 |
|
RU2508099C2 |
| NOVEL SALT AND MEDICAL APPLICATION | 2012 |
|
RU2609011C2 |
